Back to Search
Start Over
Clinical impact of genetic alterations including germline DDX41mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
- Source :
- Leukemia; April 2024, Vol. 38 Issue: 4 p918-922, 5p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 08876924 and 14765551
- Volume :
- 38
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- Leukemia
- Publication Type :
- Periodical
- Accession number :
- ejs65508466
- Full Text :
- https://doi.org/10.1038/s41375-024-02180-3